Mechanical thrombectomy treatment is cost-effective for patients with stroke: Medtronic study
07th November, 2024
First dedicated industry sponsored registry on the use of mechanical thrombectomy devices in patients for acute ischemic stroke (AIS)
Medtronic, a global leader in healthcare technology, has unveiled results from the Prospective Registry for Assessment of Acute Ischemic Stroke Patients Treated with stroke Devices in India (PRAAN) at the World Stroke Congress 2024, held in Abu Dhabi.
PRAAN is India’s first industry-sponsored dedicated registry on mechanical thrombectomy, collecting real-world data on the use of stroke devices in patients with acute ischemic stroke (AIS) caused by large vessel occlusion. The multi-centre study evaluates the clinical outcomes associated with market-released stroke devices of Medtronic for AIS patients with large vessel occlusion condition.
The PRAAN registry enrolled 200 patients over 24 months, across 14 centres, and demonstrated that mechanical thrombectomy is a safe, effective, as well as cost-effective treatment for AIS in India. The data from the PRAAN study demonstrated high rates of positive functional outcomes and procedural success of mechanical thrombectomy with a low mortality rate in AIS patients.
Discussing the PRAAN registry, Mandeep Singh Kumar, Vice President and Managing Director, Medtronic India, said, “Stroke is the fourth leading cause of death in India, making it one of the top non-communicable diseases in the country. PRAAN is a first-of-its kind multi-centric prospective stroke clinical registry in India that tracks and reports on mechanical thrombectomy. We are confident that the data and outcomes from the study will help ignite critical discourse to raise awareness about the dangers of stroke and available treatment pathways and will empower healthcare professionals and policy makers alike in providing the right resources and guidance for the Indian public.”
Medtech Special
- Roche revolutionizes diagnostics with cobas mass spec solution
- Abbott announces first-in-world leadless pacing procedures in the left bundle branch area of the heart
- BD and Babson Diagnostics launch innovative fingertip blood testing to health care organizations
- Implantica adds a ninth RefluxStop™ Center of Excellence
- Medtech firm Getinge opens new Experience Centre in Mumbai
- WHO announces first prequalification of tuberculosis diagnostic test
- Chi Mei Medical Center and Microsoft: Transforming Healthcare with AI and Smart Technology
Artificial Intelligence Breakthroughs
- Samsung invests in generate biomedicines to advance AI-driven therapeutics
- India-based 'Mahajan Imaging and Labs' launches AI-powered lab in Gurugram
- Saudi Arabia to develop AI and data science solution for tackling tuberculosis
- How AI is Propelling Radiology & Medical Imaging Capabilities
- Generative AI: Revolutionizing Diagnostics and Personalized Care
- Indian startup Qure.ai joins hands with Roche to transform healthcare capabilities in APAC
- A10 Networks Launches Integrated AI and Security Solutions to Strengthen Cybersecurity in Healthcare and Beyond
Robots In Medtech
- India's SS Innovations makes history with first robotic cardiac surgery in Indonesia
- Momentis Surgical Secures FDA Clearance for Advanced Anovo® Robotic Platform, Setting New Standards in Single-Incision Surgery
- Momentis Surgical expands to general surgery market with FDA 510(k) clearance for its Anovo Robotic system
- Intuitive and India-based KIMS Hospitals sign MoU to launch 25 new robotic surgery programmes
- ZEISS introduces its latest Robotic Visualisation System for neuro surgery
- Surgical robotics pioneer Intuitive opens Global Capability Centre in Bengaluru, India
- First-of-its-kind robotic cardiac CoE unveiled in Bengaluru, India
© 2023 MM Activ Sci-Tech Communications. All rights reserved | Disclaimer